跳至主要内容
临床试验/NCT05076110
NCT05076110已完成4 期

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2022年4月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Mayo Clinic
入组人数
86
试验地点
2
主要终点
Change in pain score

研究概览

简要总结

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 60 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

排除标准

  • medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
  • Substantial alcohol or drug abuse.
  • History of narcotics within 6 months of surgery.
  • Pregnancy.
  • Renal impairment.
  • Peptic ulcer disease.
  • GI bleeding.

研究组 & 干预措施

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Acetaminophen (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Methocarbamol (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Ibuprofen (Drug)

Standard of Care Group

Active Comparator

Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure

干预措施: Oxycodone (Drug)

Non-Opiate Pain Control Group

Experimental

Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.

干预措施: Gabapentin (Drug)

结局指标

主要结局

Change in pain score

时间窗: Baseline, 14 days post-operatively

Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor
主要研究者

Kelechi R. Okoroha

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

Nonopioid Pain Control Regimen After Arthroscopic... | 临床试验